ReviewCancer drug resistance (Alhambra, Calif.)2019

The use of pharmacogenetics to increase the safety of colorectal cancer patients treated with fluoropyrimidines.

Elena De Mattia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.